Publications by authors named "Kenneth D Levy"

Claim this Profile
T
The INGENIOUS trial: Impact of pharmacogenetic testing on adverse events in a pragmatic clinical trial.
Michael T Eadon, Marc B Rosenman, Pengyue Zhang, Cathy R Fulton, John T Callaghan, Kenneth D Levy

Pharmacogenomics J· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Network.
Kenneth D Levy, Kathryn Blake, Colette Fletcher-Hoppe, James Franciosi, Daisuke Goto

Genet Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies to Integrate Genomic Medicine into Clinical Care: Evidence from the IGNITE Network.
Nina R Sperber, Olivia M Dong, Megan C Roberts, Paul Dexter, Amanda R Elsey, Kenneth D Levy

J Pers Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Developing a common framework for evaluating the implementation of genomic medicine interventions in clinical care: the IGNITE Network's Common Measures Working Group.
Lori A Orlando, Nina R Sperber, Corrine Voils, Marshall Nichols, Rachel A Myers, Kenneth D Levy, Mia Levy

Genet Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Network.
Kenneth D Levy, Kathryn Blake, Colette Fletcher-Hoppe, James Franciosi, Diasuke Goto

Genet Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enrollment of Diverse Populations in the INGENIOUS Pharmacogenetics Clinical Trial.
Ebony Shah-Williams, Kenneth D Levy, Yong Zang, Ann M Holmes, Christa Stoughton

Front Genet· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Network.
Kenneth D Levy, Kathryn Blake, Colette Fletcher-Hoppe, James Franciosi, Diasuke Goto

Genet Med· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IGNITE network: Response of patients to genomic medicine interventions.
Lori A Orlando, Corrine Voils, Carol R Horowitz, Rachel A Myers, Meghan J Arwood, Kenneth D Levy

Mol Genet Genomic Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-gene and drug-drug interactions associated with tramadol and codeine therapy in the INGENIOUS trial.
Cathy R Fulton, Yong Zang, Zeruesenay Desta, Marc B Rosenman, Ann M Holmes, Kenneth D Levy

Pharmacogenomics· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Network.
Kenneth D Levy, Kathryn Blake, Colette Fletcher-Hoppe, James Franciosi, Daisuke Goto

Genet Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physician-Reported Benefits and Barriers to Clinical Implementation of Genomic Medicine: A Multi-Site IGNITE-Network Survey.
Aniwaa Owusu Obeng, Kezhen Fei, Kenneth D Levy, Amanda R Elsey, Toni I Pollin

J Pers Med· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing a common framework for evaluating the implementation of genomic medicine interventions in clinical care: the IGNITE Network's Common Measures Working Group.
Lori A Orlando, Nina R Sperber, Corrine Voils, Marshall Nichols, Rachel A Myers, Kenneth D Levy, Mia Levy

Genet Med· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges and strategies for implementing genomic services in diverse settings: experiences from the Implementing GeNomics In pracTicE (IGNITE) network.
Nina R Sperber, Janet S Carpenter, Larisa H Cavallari, Laura J Damschroder, Rhonda M Cooper-DeHoff, Kenneth D Levy, Mia A Levy

BMC Med Genomics· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons Learned When Introducing Pharmacogenomic Panel Testing into Clinical Practice.
Marc B Rosenman, Brian Decker, Kenneth D Levy, Ann M Holmes, Victoria M Pratt

Value Health· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomically actionable medications in a safety net health care system.
Janet S Carpenter, Marc B Rosenman, Mitchell R Knisely, Brian S Decker, Kenneth D Levy

SAGE Open Med· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA's draft guidance on laboratory-developed tests increases clinical and economic risk to adoption of pharmacogenetic testing.
Kenneth D Levy, Victoria M Pratt, Todd C Skaar, Gail H Vance, David A Flockhart

J Clin Pharmacol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report of new haplotype for ABCC2 gene: rs17222723 and rs8187718 in cis.
Victoria M Pratt, Brittany N Beyer, Daniel L Koller, Todd C Skaar, David A Flockhart, Kenneth D Levy

J Mol Diagn· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis